Avigen
Avigen, Inc. is described as a biopharmaceutical company founded in 1992 in Huntsville, United States, focused on developing therapeutics for neurological and other conditions; however, its primary domain is currently parked and no active operations could be verified.
- Company typePrivate
- Founded1992
- HeadquartersHuntsville, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Avigen firmographics
Firmographics- Name
- Avigen
- Legal name
- Avigen
- Website
- https://avigen.com
- Company type
- Private
- Founded year
- 1992
- Headcount range
- 1,001–5,000 employees
- Short description
- Avigen, Inc. is described as a biopharmaceutical company founded in 1992 in Huntsville, United States, focused on developing therapeutics for neurological and other conditions; however, its primary domain is currently parked and no active operations could be verified.
- Ownership category
- akta.pro rank
Where Avigen is headquartered
LocationHeadquarters
- HQ city
- Huntsville
- HQ country
- United States
- HQ region
- North America
Markets served
Avigen business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Avigen product offering
Product offeringCore offering
Avigen, Inc. is described in firmographic records as a biopharmaceutical company that engages in identifying and developing products to treat patients with neurological and other conditions. The firm was founded in 1992 and is based in Huntsville, United States. No live products, pipeline assets, or operational details are currently evidenced.
Differentiator
Problem solved
Functional benefit
Avigen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Avigen competitors and assessment
Company assessmentBroad incumbents
- Supernus Pharmaceuticals: Specialty pharma company focused on CNS therapeutics, including treatments for epilepsy and other neurological conditions. Overlapping therapeutic and channel characteristics.
- Jazz Pharmaceuticals: Specialty biopharmaceutical company with a significant neurology and CNS therapy portfolio. Broader and more established than Avigen but overlapping therapeutic category.
Direct peers
- Biogen: Neurology-focused biopharmaceutical company developing therapies for neurological and neurodegenerative diseases. Directly comparable to Avigen's stated neurological therapeutic focus.
- Acadia Pharmaceuticals: Specialty biopharma focused on neurological and central nervous system disorders. Comparable therapeutic area and specialty-pharma model to Avigen.
- Sage Therapeutics: Biopharmaceutical company developing CNS-targeted therapies for neurological conditions. Comparable specialty neuro focus and development-stage profile.
- Biohaven Pharmaceuticals: Neurology-focused biopharma developing therapies for neurological and psychiatric diseases. Directly comparable therapeutic category.
Emerging players
- Marinus Pharmaceuticals: Emerging neurology-focused biopharma developing therapeutics for seizure disorders and rare neurological conditions. Comparable specialty neuro pipeline orientation.
Market position
Customer concentration
Avigen social profiles
Digital presenceAvigen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Avigen leadership team
Management profileNumber of profiles
Avigen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Avigen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Avigen
What does Avigen do?
Avigen, Inc. is described in firmographic records as a biopharmaceutical company that engages in identifying and developing products to treat patients with neurological and other conditions. The firm was founded in 1992 and is based in Huntsville, United States. No live products, pipeline assets, or operational details are currently evidenced.
When was Avigen founded?
Avigen was founded in 1992. It employs 1,001 to 5,000 people.
Where is Avigen based?
Avigen is headquartered in Huntsville, United States, in the North America region.
Who are Avigen's main competitors?
Broad incumbents on record are Supernus Pharmaceuticals and Jazz Pharmaceuticals. Direct peers are Biogen, Acadia Pharmaceuticals, Sage Therapeutics and Biohaven Pharmaceuticals. Marinus Pharmaceuticals is listed as an emerging player.
Does Avigen have an API?
No public API is recorded for Avigen.